Factors associated with higher odds of poor control were insulin monotherapy and a treatment duration of ≥7 years, while being overweight and having uncontrolled blood pressure were associated with lower odds.
Frontiers in Clinical Diabetes and Healthcare · 3 authors, 2 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
Factors associated with higher odds of poor control were insulin monotherapy and a treatment duration of ≥7 years, while being overweight and having uncontrolled blood pressure were associated with lower odds.
The central finding was a high prevalence of poor glycaemic control (67.6%). Multivariable analysis identified that monotherapy with insulin and a treatment duration of ≥7 years were associated with increased odds of poor control. Conversely, being overweight and having uncontrolled blood pressure were associated with reduced odds.